NutraLife BioSciences, Inc. (NLBS)

NutraLife BioSciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Net Income	0	-7.68	-2.9	-4.07	-2.07
Depreciation & Amortization	0	0.33	0.39	0.23	0.07
Share-Based Compensation	0	2.57	0.5	0.61	0
Other Operating Activities	-	4.3	0.72	0.3	1.77
Operating Cash Flow	0	-0.49	-1.28	-2.93	-0.23
Capital Expenditures	0	0	0	-1.59	-0.58
Other Investing Activities	-	-0.68	-	-	-0.04
Investing Cash Flow	0	-0.68	0	-1.59	-0.62
Common Stock Issued	0	0.35	0.13	2.78	0.62
Other Financing Activities	-	0.95	1.15	1.34	0.48
Financing Cash Flow	0	1.3	1.27	4.12	1.1
Net Cash Flow	0	0.14	-0.01	-0.41	0.25
Free Cash Flow	0	-0.49	-1.28	-4.53	-0.82
Free Cash Flow Margin	-	-77.78%	-102.27%	-212.26%	-21.99%
Free Cash Flow Per Share	-	-0.00	-0.01	-0.04	-0.01

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.